Taiwan Liposome Ltd (TLC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TLC Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Taiwan Liposome Ltd balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2020)
0 0 0 (Dec 31 2019)
Assets
Cash And Cash Equivalents47.82
Current Tax Assets Current0.02
Cash & Short-term Investments47.00
Accounts receivable0.33
Other Noncurrent Assets4.50
Total Current Assets51.00
Equipment/Property/Plant Net4.43
Intangible Assets0.04
Deferred Tax Assets0.00
Other Assets, Noncurrent5.20
Total Assets62.30
Liabilities
Short-term Debt4.10
Other Liabilities, Current0.00
Total Current Liabilities12.40
Long-term debt0.36
Total Long-term Debt0.36
Noncurrent Provisions0.23
Total Liabilities31.56
Stockholders' Equity
Other Equity30.81
Common Stockholder's Equity30.81
Total Stockholder's Equity30.75
Liabilities & Stockholder's Equity62.30
4 historic quarters locked

Sign in to unlock the full Taiwan Liposome Ltd balance sheet history.

About TLC Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.